Publications by authors named "Finn R"

Translational silence of spermatozoa has long been considered the norm in animals. However, studies in mammals have shown that the mitochondrial ribosomal machinery is selectively activated during capacitation in the female reproductive tract, while cytosolic ribosomes remain inactive. Here, using quantitative proteomics in a piscine model species, we show that proteins involved in mRNA processing and cytoplasmic translation are predominantly accumulated in immature spermatozoa within the extratesticular excurrent ducts, while those related to flagellar motility are enriched in ejaculated (mature) sperm.

View Article and Find Full Text PDF
Article Synopsis
  • TACE is the standard treatment for patients with unresectable, non-metastatic hepatocellular carcinoma, and this study evaluates the effectiveness of adding lenvatinib and pembrolizumab to TACE compared to a placebo.
  • The multicenter, randomised, double-blind phase 3 study (LEAP-012) involved participants from 137 sites across 33 countries who were randomly assigned to receive either TACE with the new drugs or TACE with a placebo.
  • The primary endpoints were progression-free survival and overall survival, and the results reported are from the first interim analysis, which serves as the final analysis for progression-free survival.
View Article and Find Full Text PDF

The HoloFood project used a hologenomic approach to understand the impact of host-microbiota interactions on salmon and chicken production by analysing multiomic data, phenotypic characteristics, and associated metadata in response to novel feeds. The project's raw data, derived analyses, and metadata are deposited in public, open archives (BioSamples, European Nucleotide Archive, MetaboLights, and MGnify), so making use of these diverse data types may require access to multiple resources. This is especially complex where analysis pipelines produce derived outputs such as functional profiles or genome catalogues.

View Article and Find Full Text PDF

The continuous use of synthetic insecticides to suppress mosquito larvae has detrimental impacts on the environment and human health. Finding novel and target-specific bio-insecticides has become crucial. Here, the larvicidal and genotoxic activities of different extracts from and toward larvae were investigated.

View Article and Find Full Text PDF

Introduction: Atezolizumab plus bevacizumab significantly improved overall survival (OS) and progression-free survival (PFS) versus sorafenib in patients with unresectable hepatocellular carcinoma (HCC) in IMbrave150. Efficacy and safety in patient subpopulations with Vp4 portal vein tumor thrombosis (PVTT) and other high-risk prognostic factors are reported.

Methods: IMbrave150 was a global, randomized (2:1), open-label, phase 3 study in systemic treatment-naive patients with unresectable HCC; OS and PFS were co-primary endpoints.

View Article and Find Full Text PDF

Ensembl (www.ensembl.org) is an open platform integrating publicly available genomics data across the tree of life with a focus on eukaryotic species related to human health, agriculture and biodiversity.

View Article and Find Full Text PDF
Article Synopsis
  • Non-radiative Auger-Meitner recombination processes in III-nitride optoelectronic devices can lead to efficiency drops at high temperatures and carrier densities, but understanding of these processes in UV-operating devices is limited.
  • The study investigates the temperature dependence of Auger-Meitner recombination in (Al,Ga)N/AlN quantum wells using a model that considers alloy fluctuations and carrier localization effects.
  • Results indicate that while radiative recombination slightly increases with temperature, Auger-Meitner recombination may decrease, suggesting that other non-radiative processes outside the active region are likely responsible for the thermal efficiency drop in these devices.
View Article and Find Full Text PDF

The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) is one of the world's leading sources of public biomolecular data. Based at the Wellcome Genome Campus in Hinxton, UK, EMBL-EBI is one of six sites of the European Molecular Biology Laboratory, Europe's only intergovernmental life sciences organization. This overview summarizes the latest developments in services that EMBL-EBI data resources provide to scientific communities globally (https://www.

View Article and Find Full Text PDF

GENCODE produces comprehensive reference gene annotation for human and mouse. Entering its twentieth year, the project remains highly active as new technologies and methodologies allow us to catalog the genome at ever-increasing granularity. In particular, long-read transcriptome sequencing enables us to identify large numbers of missing transcripts and to substantially improve existing models, and our long non-coding RNA catalogs have undergone a dramatic expansion and reconfiguration as a result.

View Article and Find Full Text PDF

The management of hepatocellular carcinoma (HCC) is undergoing transformational changes due to the emergence of various novel immunotherapies and their combination with image-guided locoregional therapies. In this setting, immunotherapy is expected to become one of the standards of care in both neoadjuvant and adjuvant settings across all disease stages of HCC. Currently, more than 50 ongoing prospective clinical trials are investigating various end points for the combination of immunotherapy with both percutaneous and catheter-directed therapies.

View Article and Find Full Text PDF

In lichen research, metagenomes are increasingly being used for evaluating symbiont composition and metabolic potential, but the overall content and limitations of these metagenomes have not been assessed. We reassembled over 400 publicly available metagenomes, generated metagenome-assembled genomes (MAGs), constructed phylogenomic trees, and mapped MAG occurrence and frequency across the data set. Ninety-seven percent of the 1,000 recovered MAGs were bacterial or the fungal symbiont that provides most cellular mass.

View Article and Find Full Text PDF
Article Synopsis
  • * Lenvatinib achieved an objective response rate of 18.8% according to standard imaging criteria (RECIST v1.1) and 40.6% using a modified version (mRECIST), with responses noted early and lasting several months.
  • * The study observed that tumor responses occurred in patients with more severe disease, highlighting lenvatinib's effectiveness even in challenging cases, although treatment-related adverse events were common
View Article and Find Full Text PDF
Article Synopsis
  • The RATIONALE-301 study compared the cancer treatments tislelizumab and sorafenib in adults with unresectable hepatocellular carcinoma, finding tislelizumab met the goal of noninferiority in overall survival.
  • The research utilized various health-related quality of life (HRQOL) assessments and revealed that patients on tislelizumab reported better HRQOL outcomes, particularly in aspects of fatigue and physical functioning, compared to those on sorafenib.
  • Overall, tislelizumab not only showed better quality of life results but also had a favorable safety profile, marking it as a promising first-line treatment option for patients with hepatocellular carcinoma.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to link the histopathologic grade of LI-RADS 5 hepatocellular carcinoma (HCC) from preablation needle biopsies to outcomes like local tumor control and overall survival post-thermal ablation.
  • It involved 133 adult patients with confirmed LI-RADS 5 HCC, finding no difference in local tumor control rate, but poorly differentiated tumors showed significantly worse intrahepatic progression-free survival and lower overall survival compared to better-differentiated ones.
  • The results suggest that patients with poorly differentiated LI-RADS 5 HCC face greater challenges in preventing tumor progression after thermal ablation compared to those with well- or moderately differentiated tumors.
View Article and Find Full Text PDF

Motivation: Metagenome-Assembled Genomes (MAGs) or Single-cell Amplified Genomes (SAGs) are often incomplete, with sequences missing due to errors in assembly or low coverage. This presents a particular challenge for the identification of true gene frequencies within a microbial population, as core genes missing in only a few assemblies will be mischaracterized by current pangenome approaches.

Results: Here, we present CELEBRIMBOR, a Snakemake pangenome analysis pipeline which uses a measure of genome completeness to automatically adjust the frequency threshold at which core genes are identified, enabling accurate core gene identification in MAGs and SAGs.

View Article and Find Full Text PDF

Spermatozoon volume regulation is an essential determinant of male fertility competence in mammals and oviparous fishes. In mammals, aquaporin water channels (AQP3, -7 and -8) have been suggested to play a role in spermatozoon cell volume regulatory responses in the hypotonic female oviduct. In contrast, the ejaculated spermatozoa of marine teleosts, such as the gilthead seabream (), experience a high hypertonic shock in seawater, initially resulting in an Aqp1aa-mediated water efflux, cell shrinkage and the activation of motility.

View Article and Find Full Text PDF

Fungal pathogens pose significant threats to plant health by secreting effectors that manipulate plant-host defences. However, identifying effector proteins remains challenging, in part because they lack common sequence motifs. Here, we introduce Fungtion (Fungal effector prediction), a toolkit leveraging a hybrid framework to accurately predict and visualize fungal effectors.

View Article and Find Full Text PDF

Purpose: Durable partial response (PR) and durable stable disease (SD) are often seen in patients with hepatocellular carcinoma (HCC) receiving atezolizumab plus bevacizumab (atezo-bev). This study investigates the outcome of these patients and the histopathology of the residual tumors.

Patients And Methods: The IMbrave150 study's atezo-bev group was analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • Anti-PD1/L1 immunotherapy has shown promise when combined with chemotherapy for advanced biliary tract cancer (BTC), yet no predictive biomarker has been identified for its effectiveness.
  • Researchers analyzed tumor-infiltrating lymphocytes (TIL) using AI-powered immune phenotype (AI-IP) analysis on tissue samples from 339 advanced BTC patients undergoing anti-PD1 treatment.
  • The study found that patients with an "inflamed" immune phenotype (high TIL) had significantly better treatment responses and survival rates compared to those with "noninflamed" phenotypes, suggesting AI-IP could be a useful predictor of outcomes for anti-PD1 therapy in BTC.
View Article and Find Full Text PDF

Cyanobacteria are globally occurring photosynthetic bacteria notable for their contribution to primary production and production of toxins which have detrimental ecosystem impacts. Furthermore, cyanobacteria can form mutualistic symbiotic relationships with a diverse set of eukaryotes, including land plants, aquatic plankton and fungi. Nevertheless, not all cyanobacteria are found in symbiotic associations suggesting symbiotic cyanobacteria have evolved specializations that facilitate host-interactions.

View Article and Find Full Text PDF

Introduction: Lenvatinib (dosing for patients who weigh ≥60 kg was 12 mg/day; for patients who weigh <60 kg, the dose was 8 mg/day) plus pembrolizumab 200 mg once every 3 weeks demonstrated antitumor activity and a manageable safety profile in patients with first-line unresectable hepatocellular carcinoma (uHCC) in the open-label phase 1b Study 116/KEYNOTE-524 (primary analysis data cutoff date: October 31, 2019; median follow-up: 10.6 months). This analysis (updated data cutoff date: March 31, 2021) reports efficacy results from 17 months of additional follow-up time.

View Article and Find Full Text PDF

Introduction: The phase III IMbrave150 study established atezolizumab + bevacizumab as the global standard of care in patients with unresectable hepatocellular carcinoma (HCC). This exploratory analysis examined the impact of bevacizumab interruption due to bevacizumab adverse events of special interest (AESIs).

Methods: Patients in IMbrave150 who were randomized to atezolizumab + bevacizumab and received treatment for ≥6 months (to reduce immortal time bias) were included in group A-1 if bevacizumab had ever been skipped due to bevacizumab AESIs or to group A-2 otherwise.

View Article and Find Full Text PDF

Background: Prophylactic antibiotics are routinely prescribed by surgeons for their patients who undergo septorhinoplasty. However, the literature to support this remains controversial, especially in complex cases, those that require grafts, revision cases, extended surgical time, and an American Society of Anesthesiologists (ASA) value greater than or equal to 3.

Purpose: The study purpose was to evaluate for a potential association between increased anesthetic complexity and the risk for surgical site infection (SSI) following complex septorhinoplasty.

View Article and Find Full Text PDF

Volume regulation is essential for cell homeostasis and physiological function. Amongst the sensory molecules that have been associated with volume regulation is the transient receptor potential vanilloid 4 (TRPV4), which is a non-selective cation channel that in conjunction with aquaporins, typically controls regulatory volume decrease (RVD). Here we show that the interaction between orthologous AQP4 (Aqp4a) and TRPV4 (Trpv4) is important for regulatory volume increase (RVI) in post-activated marine fish spermatozoa under high osmotic stress.

View Article and Find Full Text PDF